Who
Mark H. Pavao
Director
Company insider
Files Form 4 as: Director, Coya Therapeutics; SVP of Sales and Marketing, Nitromed.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 19 Jan 2006
- Last trade
- 9 Apr 2026
- Last filed
- 9 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Apr 2026filed 9 Apr 2026 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 9 Apr 2026filed 9 Apr 2026 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 30 Mar 2006filed 3 Apr 2006 | Nitromedoption or derivative | SEC FORM 4 Code A | —43,000 at $0.00 | filing |
| 19 Jan 2006filed 15 Feb 2006 | Nitromedoption or derivative | SEC FORM 4 Code A | —34,400 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.